psychology of psychedelic drugs
Katz, Martin. (1968). Characterizing the psychological state produced by lsd. Journal of Abnormal Psychology, 73(1), 1-14. doi: 10.1037/h0020114 This article shows the results of trials using 69 prison inmates and administering LSD, amphetamine, and a control saline to explore their effects on emotion. These results, showing three main mental states of LSD intoxication, were predicted to be useful in further exploring the psychological origin of emotions.
Check, Erika. (2004). Psychedelic drugs: The ups and downs of ecstasy. Nature, 429(6988), 126. Retrieved from http://www.nature.com/nature/journal/v429/n6988/full/429126a.html In this nature journal, the therapeutic uses of MDMA (ecstasy) are tested on patients with PTSD. The article explains how the empatheogenic effects of this drug could possibly allow one to open up to others with more trust and confidence, perhaps allowing alleviation from the PTSD. The long term effects of only a session or several sessions with MDMA could permanently affect the emotional outlook of one suffering from PTSD.
Macready, Norra. (2012). Opening doors of perception: psychedelic drugs and end-of-life care. Journal of the National Cancer Institute, 104(21), 1619-20. Retrieved from http://jnci.oxfordjournals.org/content/104/21/1619.full Using primarily psilocybin mushrooms as the drug of interest, this article explains how classic psychedelic drugs (LSD, mushrooms, mescaline, DMT, and MDMA) could aid the weakened mental state of those terminally ill. The author shows that patients feel a connectedness to the “energy” of life and have much less fear of death long after the psychoactive effects of these drugs has worn off.
Carhart-harris, Robin L. (2012). Neural correlates of the psychedelic state as determined by fmri studies with psilocybin. Proceedings of the National Academy of Sciences of the United States of America, 109(6), 2138-43. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277566/ A very
Check, Erika. (2004). Psychedelic drugs: The ups and downs of ecstasy. Nature, 429(6988), 126. Retrieved from http://www.nature.com/nature/journal/v429/n6988/full/429126a.html In this nature journal, the therapeutic uses of MDMA (ecstasy) are tested on patients with PTSD. The article explains how the empatheogenic effects of this drug could possibly allow one to open up to others with more trust and confidence, perhaps allowing alleviation from the PTSD. The long term effects of only a session or several sessions with MDMA could permanently affect the emotional outlook of one suffering from PTSD.
Macready, Norra. (2012). Opening doors of perception: psychedelic drugs and end-of-life care. Journal of the National Cancer Institute, 104(21), 1619-20. Retrieved from http://jnci.oxfordjournals.org/content/104/21/1619.full Using primarily psilocybin mushrooms as the drug of interest, this article explains how classic psychedelic drugs (LSD, mushrooms, mescaline, DMT, and MDMA) could aid the weakened mental state of those terminally ill. The author shows that patients feel a connectedness to the “energy” of life and have much less fear of death long after the psychoactive effects of these drugs has worn off.
Carhart-harris, Robin L. (2012). Neural correlates of the psychedelic state as determined by fmri studies with psilocybin. Proceedings of the National Academy of Sciences of the United States of America, 109(6), 2138-43. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277566/ A very